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Background: Chronic Epstein Barr virus (EBV) infection in an immunocompetent host has been described however
it is not a common entity. It has been linked to many lymphoproliferative disorders and achieves such via many
molecular mechanisms, some of which are poorly understood. In addition to infectious mononucleosis, the EBV is
linked to various other hematological pathologies and autoimmune disorders.
Case presentation: We describe the case of an elderly immunocompetent female who presented with non-
specific symptomatology, lymphadenopathy, cytopenias, elevated autoantibody titers and a crescent EBV viral load
that were suggestive of a multisystemic inflammatory disease related to EBV. Extensive work up including multiple
bone marrow biopsy and lymphoid tissue procedures ultimately led to the diagnosis of Hodgkin lymphoma.
Conclusion: EBV-related lymphomagenesis is complex and through the utilization of its nuclear antigens and latent
membrane proteins the virus is able to shape the microenvironment to promote the various pathologies seen.
Moreover, the diagnosis of EBV-associated lymphoproliferative disorders might be challenging when they present in
immunocompetent individuals. Our case also represents an emphatic reminder for clinicians that spontaneous
regression of lymphadenopathy is not exclusive of low-grade lymphoid malignancies.
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Infectious mononucleosis is considered a common world-
wide infection, with a lifetime prevalence of 90 %. EBV is
the major cause of infectious mononucleosis 90 % of the
time. It is a double stranded DNA virus that belongs to
the family Herpesviridae and subfamily Gamma herpesvir-
idae [1]. Clinically many entities may mimic infectious
mononucleosis thus careful examination and history tak-
ing must ensue to ensure proper diagnosis and manage-
ment. It is defined as the classical triad of fever,
pharyngitis, and cervical lymphadenopathy along with
lymphocytosis. The challenge herein lies in the nonspecific
prodromal symptoms such as fevers, chills, and malaise
which may mimic various other bacterial, viral, or fungal
infections. The lymphadenopathy may be prominent in
the anterior as well as the posterior triangles of the neck.
Furthermore, certain patients may exhibit palatal
petechiae, splenomegaly, hepatomegaly, and jaundice.* Correspondence: CMRojas@mdanderson.org
3Section of Benign Hematology, University of Texas MD Anderson Cancer
Center, Houston, TX, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeThe acute viral infection generally resolves within 2–4
weeks. Most cases can be treated with conservative mea-
sures such as rest, hydration, analgesics, and antipyretics.
In most cases of infectious mononucleosis, splenomegaly
resolves by 4–6 weeks.
Less commonly, EBV infection may cause further
neurological and hematological complications such as
immune mediated cytopenias. EBV has been implicated
in several autoimmune diseases, most notably systemic
lupus erythematosus, rheumatoid arthritis and multiple
sclerosis. It is postulated that EBV may be an early envir-
onmental trigger of such autoimmune diseases [2].
The virus can remain in a latent status with genome
persisting in the nucleus of infected cells in the form of
non-integrated circular episomes that have a nucleo-
somal pattern similar to the host chromatin. Through
histone modification and DNA methylation, viral
promoters are regulated for the lytic cell cycle reactiva-
tion. The EBV latent episomes have also the capacity to
influence the epigenetic state of the host DNA and result
into modulation of tumor suppressor gene expression
and carcinogenesis, including lymphomas [3].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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include Burkitt lymphoma, and Hodgkin lymphoma.
Other described types of malignant neoplasms associated
to EBV include plasmablastic lymphoma, EBV-positive
diffuse large B-cell lymphoma, primary effusion lymph-
oma, classical Hodgkin lymphoma, T/NK lymphoprolifer-
ative disorders and lymphomatoid granulomatosis [4, 5].
Case presentation
A 69 year old Hispanic female with a past medical history
significant for hypertension, diabetes mellitus, coronary
artery disease status post revascularization, ischemic car-
diomyopathy and chronic kidney disease had presented to
our hospital for further evaluation and care. For the past
few months the patient had suffered weight loss (approxi-
mately 30–35 lb), generalized malaise, low grade fevers
(99.9 F), non-productive cough, myalgias and arthralgias.
She did not endorse any night sweats or recent travel his-
tory, and there were no sick contacts at home. Prior to ad-
mission to our institution the patient was at an outside
hospital and was being treated for sepsis with combina-
tions of antibiotics including intravenous vancomycin,
meropenem, echinocandin, metronidazole, and piperacil-
lin tazobactam for 2 to 3 weeks duration as she was devel-
oping fevers and productive cough.
The physical exam yielded a thin and chronically ill
appearing female patient.
Vital signs at the time of admission were notable for
hypertension (186/79 mmHg). Her eyes did not show any
conjunctival hemorrhaging or icterus, however there was
conjunctival pallor. Oropharynx did not show any active
exudates or ulcerative lesions. Her cardiac exam did not re-
veal any murmurs and her airways were clear to ausculta-
tion. Abdominal exam revealed palpable splenomegaly.
Examination of the extremities did not show nail deform-
ities including splinter hemorrhages or nail pitting. Her skin
had no evidence of skin nodularities or other lesions. There
was a 1 cm non tender, movable left axillary lymph node.
The rest of the physical examination was unremarkable.
Initial laboratory work revealed that the patient had
pancytopenia. White blood cell count (WBC) was stated
at 2.4 K/uL, absolute neutrophil count (ANC) 1.92 K/
uL, hemoglobin (Hgb) of 11.6, and platelet count of
39,000/uL. B2-microglobulin was seen elevated at
9.2 mg/L. Basic metabolic panel obtained showed so-
dium 134 mEq/L, Potassium 3.5 mEq/L, Chloride
103 mEq/L, Bicarbonate 26 mEq/L, Blood urea nitrogen
30 mg/dl, Creatinine 0.90 mg/dl, glucose 220 mg/dl.
Liver function panel showed Albumin 2.2 g/dl, normal
transaminases, total bilirubin 0.8 mg/dl, direct bilirubin
0.4 mg/dl. Urine analysis showed 200 mg/dl of protein
and occasional amorphous crystals.
Initial computed tomography (CT) scan of the abdomen
and pelvis during hospital admission showed a 15 cm spleenwhich was heterogenous and micronodular, as well as scat-
tered abdominal and pelvic lymphadenopathy (Fig. 1a). No
imaging signs of portal hypertension were noted.
During the hospitalization our patient was noted to
become more confused and agitated, and there was con-
cern that the patient was having seizures as she was seen
numerous times to lose consciousness and awaken, with
occasional loss of bladder function. A brain magnetic
resonance imaging (MRI) showed subcortical non en-
hancing FLAIR hyper intense foci in the bilateral poster-
ior occipital lobes.
Lumbar puncture and cerebral spinal fluid (CSF) studies
were further performed for further analysis, and showed:
WBC 1; no red blood cells; protein 62 mg/dL; glucose
35 mg/dL; and, lactate dehydrogenase 234 mIU/mL. Most
notable negative findings in the CSF included no detectable
viral cultures for cytomegalovirus, adenovirus, herpes virus,
and varicella zoster virus, negative cryptococcal antigen ser-
ology and negative bacterial and fungal cultures.
Electroencephalogram studies showed triphasic morph-
ology waves with and without sharp negative component
at 2–3 hertz. These were seen in continuum mostly with
subtle waxing and waning features. To 0.5 mg intravenous
alprazolam, above discharges had slowly resolved, replaced
by organized background that consists of 6 hertz rhythms.
Importantly, there was a clinical improvement after
alprazolam; suggesting a nonconvulsive seizures respond-
ing to benzodiazepine.
Two weeks later after the initial CT imaging and after
the patient was more stable from the neurological per-
spective in order to attempt a lymph node excisional bi-
opsy, a PET-CT imaging was performed and showed
complete resolution of the previously detected lymph-
adenopathy and splenomegaly. (Fig. 1b).
Additional serologies for viral hepatitis and auto-
immune etiology work up were performed. A bone mar-
row biopsy was performed and additional serum
erythropoietin level, iron profile; cobalamin and folate
level were determined.
The patient returned to the benign hematology clinic
after discharged from the hospital. During her follow up
appointment she appeared in better spirits and recovering
well. Physical examination was notable for an absence of
lymphadenopathy particularly in the cervical and axillary
region, as well as no palpable organomegaly in the
abdomen. It was further revealed that her antinuclear anti-
body (ANA) titer was highly positive (1:640), ESR
108 mm/hr with a CRP 6.74 mg/L. Negative viral hepatitis
B, C and Human Immunodeficiency virus serologies.
Serum quantitative immunoglobulin showed a mildly
elevated Ig A and Ig G level, without other abnormal-
ities. Serum and urine protein electrophoresis did not re-
veal a monoclonal gammopathy. Serum free light chain
levels showed kappa 96.3 mg/L and lambda 60.06 mg/dL
c d
ba
Fig. 1 Imaging findings at disease presentation and progression. a CT abdomen and pelvis with contrast showing an enlarged spleen with
micronodular pattern. b PET-CT imaging showing interval resolution of splenomegaly and documenting no evidence of hypermetabolic
adenopathy. c Repeat CT chest with contrast evidencing development of a right axillary node measuring 2.9 × 2.4 cm and a left axillary node
measuring 3 × 1.5 cm (white arrows). d Repeat CT abdomen and pelvis evidencing again an enlarged spleen with numerous small subtle
hypodense nodules
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Complement C3 level was normal with a slightly elevated
C4 at 46 mg/dL.
Bone marrow aspirate yielded a predominance of CD3
positive polytypical small T cells and a population of
polyclonal B-cells by flow cytometry and negative for
lymphoma or other malignant process. A focal lympho-
histiocytic aggregate with granuloma formation was
noted; occasional larger cells with prominent nucleolus
identified; eosinophils were increased mildly in the vicin-
ity of this aggregate. Acid fast bacilli and fungal stains
were attempted; however the focal granuloma could not
be appreciated at subsequent sections.
The patient’s pancytopenia was thought to be likely
secondary to systemic lupus erythematosus and she was
thus referred to rheumatology for further work up, and
further testing included anti-double-stranded DNA,
anti-RNP, anti-CCP antibody, ANCA vasculitis panel,
direct antiglobulin test, lupus anticoagulant, anticardioli-
pin antibody, anti-double-stranded DNA antibody, and
anti-SSA and anti-SSB. All these tests were negative,
thus ruling out systemic erythematous lupus, rheuma-
toid arthritis, and other connective tissue disorders.The interval improvement and self-limited clinical
course in our case led us to believe that her elevated
ANA titers, her bone marrow granuloma were secondary
to an EBV infection-related syndrome. Monospot test
was not performed and at that point we evaluated for
EBV PCR and EBER staining in the bone marrow. Initial
EBV PCR results were positive (960 copies/mL), while
Epstein–Barr virus-encoded small RNAs staining in the
bone marrow was negative. Our in situ hybridization
stain is validated to work on decalcified bone marrow
trephine biopsies and all stains include an on-slide posi-
tive control. As such, the likelihood of a false negative
result is low. A possible explanation includes a sampling
factor with lack of infected B-cells in the bone marrow
despite the presence of viremia.
Her follow up labs during subsequent clinic visits
showed WBC 5.3 K/uL, ANC 3.15 K/uL, Hgb 7.4 g/dL,
calculated reticulocyte index of 1.1 and platelets 172 K/
uL. Iron was 68 ug/dL, transferrin 124.1 mg/dL, ferritin
2952 ng/mL and serum erythropoietin levels were 31.7
mIU/mL. Serum cobalamin was 394 pg/mL and serum
folate 12.3 ng/mL. Since there was spontaneous interval
resolution of her neutropenia and her thrombocytopenia
our diagnosis at that point was cytopenias secondary to
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Our patient presented 7 weeks later at the emergency
room with a recurrent febrile syndrome with diffuse cer-
vical and axillary lymphadenopathy and splenomegaly
(Fig. 1c-d) and worsening cytopenias: WBC 1800/uL, ANC
1480/uL, Hgb 8.3 gr/dL, platelet count 20,000/uL; a repeat
EBV titer revealed 6580 copies/mL. CT imaging with con-
trast found bilateral axillary, mediastinal and hilar lymph-
adenopathy. Low volume retroperitoneal and pelvic
lymphadenopathy, hepatosplenomegaly with numerous
small ill-defined hypodense lesions was in the spleen and
probably also within the liver (Fig. 1d). At this time a repeat
bone marrow biopsy and an excisional lymph node biopsy
were performed and reviewed. The bone marrow specimen
showed a solitary large cell positive for CD30 identified in
the clot. No atypical cells are identified in core biopsy as
assessed by IHC for CD30 and Pax-5. EBER was positive in
few and scattered cells. The lymph node sections demon-
strated near-total effacement of the lymph node architec-
ture by a neoplasm comprised of neoplastic cells with
Hodgkin-Reed-Sternberg morphology. The neoplastic cells
were positive for CD15, CD30, PAX5 (weak), and MUM1.
They were negative for CD3, CD20, CD45, ALK, and EMA.
The findings were diagnostic of classical Hodgkin lymph-
oma, best subtyped as lymphocyte-depleted. (Fig. 2a-c).
The expression of PAX5 with weak intensity coupled with
MUM1 expression by the neoplastic cells is diagnostic of
classical Hodgkin lymphoma. The expression of PAX5, a
gene encoding a B-cell-specific transcription factor, ex-
cluded T-cell lymphoma as a diagnostic consideration. It isa
Fig. 2 Bone marrow histopathologic findings confirming diagnosis of Hod
classical Hodgkin lymphoma. Neoplastic large lymphoid cells with Hodgkin
histiocytes, small lymphocytes, and plasma cells. b The neoplastic cells wer
B-cell marker PAX5 by immunohistochemistry (not shown). c Colorimetric i
within the neoplastic cells (blue signal)worth noting also that flow cytometry done on a bone mar-
row sample with involvement by lymphoma showed no evi-
dence of T-cell or B-cell immunophenotypic aberrancies.
The patient was started on ABVD chemotherapy re-
gime, bleomycin was held secondary to patient’s history of
cardiomyopathy. She received three cycles of chemother-
apy with complete clinical remission. Additional cycles of
chemotherapy were not completed given prolonged and
severe chemotherapy-induced cytopenias that eventually
recovered over the following months. A bone marrow
biopsy at completion of treatment revealed no morpho-
logic evidence of residual Hodgkin lymphoma. Her most
recent surveillance PET-CT imaging, nine months from
completion of treatment, showed no hypermetabolic
lymphoma and continuing complete metabolic response
to therapy.
Discussion
Hereby we have presented a challenging case of EBV
infection leading to Hodgkin lymphoma, which initially
manifested as a syndrome consisting of fever of un-
known origin, lymphadenopathy, elevated ANA titer and
cytopenias with spontaneous interval resolution suggest-
ing infectious mononucleosis versus an autoimmune dis-
order. In an adult patient complaining of chronic fever
with no true identifiable source, autoimmune disorders
and etiologies including infectious endocarditis, intra-
abdominal abscess and viral pathogens such as HIV are
within the differential diagnoses. Occult malignancies
are also etiologies of such a clinical presentation, espe-
cially in elderly population [6–8].b
c
gkin lymphoma. a Bone marrow biopsy demonstrated involvement by
-Reed-Sternberg morphology were present in a background rich in
e positive for CD30. The neoplastic cells were also positive for the
n situ hybridization was positive for Epstein-Barr virus-encoded RNA
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ANA titer of 1:40, and healthy woman are said to have a
more likelihood of positive titers relative to men. Other
non-rheumatological diseases such as thyroiditis, hepa-
titis, malignancies, infections, environmental exposures,
and prescription drugs may show the presence of ANA
[9]. Acute EBV infection or reactivation is correlated
with the presence of high ANA antibodies which gives
way to the notion that the virus causes the dysregulation
of the immune response towards self-antigens. There is
a certain level of molecular mimicry in inducing auto-
antibodies and the immune response towards EBV [9].
The next diagnostic challenge in our case was the in-
terpretation of the presence of granulomata in the bone
marrow. A variety of disorders have been implicated in
the pathogenesis of bone marrow granuloma. They in-
clude malignant lesions; viral, bacterial, and fungal infec-
tions; autoimmune diseases; drugs; and sarcoidosis [10].
The presence of non-caseating granulomata has been
described and associated with Hodgkin lymphoma and
non-hodgkin lymphoma [11–14]. In Hodgkin lymph-
oma, the frequency of involvement by granulomata in
the bone marrow is not clearly determined, and some
series have described it in up to 10 % of cases [14]. It
seems that the presence of granulomata does not trans-
late into a major difference on survival outcomes [12].
The EBV is associated with lymphoproliferative disorders
(PTLD) that comprise a vast array of lymphoid proliferations
after the organ transplant period. The patients affected com-
prise mainly those who have received either solid organ or
bone marrow transplantation. The clinical spectrum ranges
from that which mimics an inflammatory reaction to more
aggressive and lethal B cell proliferations that often resemble
non-Hodgkin lymphoma. The pathogenesis described in-
volves the donor derived B cells which have been previously
infected by EBV. With the organ recipient having insuffi-
cient T cell function, there is uninhibited growth of EBV in-
fected cells. Multiple genetic mutations ensue which
ultimately leads to virus-independent cell growth, which
often exhibit more aggressive forms of disease. These tu-
mors typically involve the transplanted organ or other re-
gions of the gastrointestinal tract, and the incidence shows a
direct relationship to the severity and duration of the im-
munosuppressive therapy [4]. Our case is unique in several
aspects. The patient did not have a history of solid organ or
hematologic transplant and she was not on pharmacologic
immunosuppression. Her only risk factor for immune com-
promise was her history of diabetes. Her syndrome initially
resembled the more benign subtypes of the PTLD which are
characterized as more inflammatory and reactive with the
regression and spontaneous resolution of lymphadenopathy
and splenomegaly, however with time the aggressive malig-
nancy was seen on biopsy as a rare entity: lymphocyte
depleted Hodgkin lymphoma (HL).Of the various subtypes of HL, the lymphocyte de-
pleted classical Hodgkin Lymphoma (LDCHL) type is
the rarest and so consequentially little information is
known about its clinical characteristics, course, and
treatment outcomes. Less than 1 % of all patients with
HL are diagnosed with LDHL. The diagnoses requires
immunohistochemical staining which can show one of
two subtypes of LDCHL; Reed-Sternberg (RS) cells in a
hypocellular background with disordered fibrosis, and
rich in histiocytes, or the reticular variant showing nu-
merous RS cells with bizarre cytologic features [5].
Unfortunately patients with the LDCHL tumor often
have more unfavorable characteristics such as more ad-
vanced stage, B symptoms, mediastinal mass, extranodal
disease, high ESR, and more lymph node involvement. Fur-
thermore patients tend to have more bone marrow and
liver involvement. Patients also have lower rates of
complete remission, progression free survival (PFS), and
overall survival (OS) relative to other patients with other
HL subtypes. Clinically those with the LD subtype have
poorer prognostic factors and poor overall outcomes [5].
Our case demonstrates the broad spectrum of EBV-related
lymphoproliferative neoplasms and the occurrence in a pa-
tient without the classic immunosuppression risk factors.
Finally, the prevalence and prognostic significance of
EBV infection in classical Hodgkin lymphoma has been
described in a recently published meta-analysis. It found
that the prevalence of EBV is more common in males and
typically seen in pediatric population, predominantly
found in the mixed cellularity subtype and in patients with
advanced clinical stage. However, the presence of EBV had
little effect on patient’s overall and event-free survival [15].Conclusion
Our case illustrates one of the different clinical features
in the spectrum of EBV infection. Age-related EBV-
associated lymphoproliferative disorders represent a well
described complication of EBV infection, typically seen
in immunosuppressed individuals [16]. Our case de-
scribes an EBV-related syndrome in an immunocompe-
tent host that mimicked features of a transient viral
illness and a systemic inflammatory disorder. Ultimately,
it declared itself with a pattern of chronicity that led to
the diagnostic presumption and histopathologic confirm-
ation of a rare subtype of classical Hodgkin lymphoma.
Moreover, this case exemplifies a scenario where the clas-
sic “waxing and waning” clinical tendency is not pathog-
nomonic of low grade lymphoproliferative disorders and
can evidently be present in high grade lymphomas.
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